Real-time near-body drug screening during autopsy I: Use of the Randox biochip drugs of abuse DOA i and DOA II immunoassays

Forensic Toxicology

Volumn 31, Issue 1, 2013, Pages 113-118

  McLaughlin, Poppy ^a   Pounder, Derrick ^b   Maskell, Peter ^b   Osselton, David ^a  

^a BOURNEMOUTH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Drugs of abuse; Immunoassay; Liver; Muscle; Postmortem; Vitreous humor

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZOYLECGONINE; BUPRENORPHINE; CANNABINOID; DEXTROPROPOXYPHENE; DIETHYLAMINE; FENTANYL; KETAMINE; LYSERGIC ACID; METHADONE; METHAMPHETAMINE; METHAQUALONE; OPIATE; OXYCODONE; PHENCYCLIDINE;

AUTOPSY; BIOCHIP; BLOOD SAMPLING; CONFERENCE PAPER; DRUG ABUSE; DRUG SCREENING; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; LIVER; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; PSOAS MUSCLE; TANDEM MASS SPECTROMETRY; VITREOUS BODY;

EID: 84872686529     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-012-0149-2     Document Type: Conference Paper

References (18)

1. Moeller KE, Lee KC, Kissack JC (2008) Urine drug screening: practical guide for clinicians. Mayo Clin Proc 86:66-76
2. Bush DM (2007) The U.S. mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int 174:111-119
3. Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McCanus CD, Brandon DE (2010) Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectrometry (LC/MS/MS). Pain Phys 13:1-22
4. Moffat AC, Osselton MD, Widdop B, Watts J (2011) Clarkes analysis of drugs and poisons. Pharmaceutical Press, London
5. Rutty GN, Rutty JE (2011) Perceptions of near virtual autopsies. J Forensic Leg Med 18:306-309
6. Rutty GN (2007) Are autopsies necessary? The role of computed tomography as a possible alternative to invasive autopsies. Rechtsmedizine 17:21-28
7. Fernandez AA, Amigo N, Carbone MT, Mora A, Pinto M, Beltran J, Gasso S (2009) Application of the Cozart DDS system to postmortem screening of drugs of abuse in vitreous humor. Forensic Toxicol 27:90-97
8. Elliott SP, Hale KA (1988) Applications of an HPLC-DAD drug screening system based on retention indices and UV spectra. J Anal Toxicol 22:280-290
9. Gunn J, Kriger S, Terrell AR (2010) Identification and quantitation of amphetamine, methamphetamine, MDMA, pseudophedrine, and ephedrine in blood, plasma, and serum using gas chromatography-mass spectrometry (GC/MS). Clin Appl Mass Spectrom 603:37-43
10. Jenkins AJ, Oblock J (2008) Phencyclidine and cannabinoids in vitreous humor. Leg Med 10:201-203
11. Scott KS, Oliver JS (2001) The use of vitreous humor as an alternative to whole blood for the analysis of benzodiazepines. J Forensic Sci 46:694-697 (Pubitemid 32520597)
12. Schutz H, Erdmann F, Magiera ES, Weiler G (1998) Analytical confirmation of error in false positive amphetamine immunoassays and results. Arch Kriminol 201:93-96
13. Kupiec T, DeCicco L, Spiehler V, Sneed G, Kemp P (2002) Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine. J Anal Toxicol 26:513-518 (Pubitemid 36206788)
14. Stout PR, Klette KL, Wiegand R (2003) Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine. J Anal Toxicol 27:265-269 (Pubitemid 36877168)
15. Savoca R, Rentsch KM, Hubert AR (2004) Diagnostic efficiency of different amphetamine screening tests - the search for an optimal cutoff. Clin Chem Lab Med 42:1063-1065 (Pubitemid 39307399)
16. Apollonio LG, Whittall IR, Pianca DJ, Kyd JM, Maher WA (2007) Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant direct ELISA presumptive assays for amphetamine and methamphetamine. J Anal Toxicol 31:208-213 (Pubitemid 46708661)
17. Broussard L (2008) Interpretation of amphetamines screening and confirmation testing. Bioanalysis 1:937-952
18. ® Drug of Abuse Panel: the cause of the unusual phenomenon with experimental analyses. Int J Leg Med 123:247-252